DR. PATRICK VINCENT ACEVEDO M.D. NPI 1639132269

NPI Details

DR. Patrick Vincent Acevedo, M.D. is a medical oncology internal medicine in Ocala, FL with 27 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Patrick Vincent Acevedo, M.D. NPI is 1639132269. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Graduation Year:1998

The provider's business location address is:

1630 SE 18TH ST STE 602
OCALA, FL
ZIP 34471-472
Phone: (352) 369-0181
Fax: (352) 369-0246

The NPI 1639132269 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood test, clotting time (HCPCS:85610)
• Protein measurement, serum (HCPCS:84165)
• Iron binding capacity (HCPCS:83550)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Magnesium level (HCPCS:83735)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Folic acid level, serum (HCPCS:82746)
• Testosterone (hormone) level, total (HCPCS:84403)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Automated urinalysis test (HCPCS:81003)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Drawing of blood for a medical problem (HCPCS:99195)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Erythropoietin (protein) level (HCPCS:82668)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Blood creatinine level (HCPCS:82565)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Red blood count, automated test (HCPCS:85045)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Vitamin d-3 level (HCPCS:82306)

The enumeration date for this NPI number is 4/6/2006 and was last updated on 8/1/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.